1.Microsatellite Instability and p53 , k-ras c-myc Oncoprotein Expression in Non-Small Cell Lung Carcinoma.
The Korean Journal of Thoracic and Cardiovascular Surgery 2000;33(1):60-67
BACKGROUND: Microsatellites are short-tandem repeated uncleotide sequences present throughout the human genome. Alterations of microsatellites have been termed microsatellite instability(MI). It has been generally known that microsatellite instability detected in hereditary non-polyposis colorectal cancer (HNPCC) reflects genetic instability that is caused by impairments of DNA mismatch repair system regarding as a novel tumorigenic mechanism. A number of studies reported that MI occurred at varying frequencies in non-small cell lung carcinoma (NSCLC). However It has been unproven whether MI could be a useful market of genetic instability and have a clinical significance in NSCLC. MATERIAL AND METHOD: We have examined whether MI can be observed in thirty NCSLC using polymerase chain reaction whether such alterations are associated with other molecular changes such as p53, K-ras and c-myc oncoproteins expression detected by immunohistochemical stain,. RESULT: MI(+) was observed in 16.6%(5/30) and MI(-) was 83.3% (25/30) Average age was 50+/-7.5 year-old in MI(+) group and 57+/-6.6 year-old in MI(-) group. Two year survival rate in MI(=) group (20% 1/5) was worse than MI(-) group (64% 16/25) with a statistic difference. (P=0.04) The positive rate of K-ras oncoprotein expression and simultaneous expression of 2 or 3 oncoproteins expression were higher in MI(+) group than MI(-) group with a statistic difference(P=0.05, P=0.01) CONCLUSIONS: From, these results the authors can conclude that MI is found in some NSCLC and it may be a novel tumorigenic mechanism in some NSCLC. We also conclude that MI could be used as another poor prognostic factor in NSCLS.
Colorectal Neoplasms
;
DNA Mismatch Repair
;
Genome, Human
;
Humans
;
Lung Neoplasms
;
Lung*
;
Microsatellite Instability*
;
Microsatellite Repeats*
;
Oncogene Proteins
;
Polymerase Chain Reaction
;
Survival Rate
2.Thoracoscopic Esophagectomy for Esophageal Cancer: One Case Report.
Jin Yong CHUNG ; Sung Mo YEON ; Gun PARK ; Moon Sub KWAK ; Seung Soo KWAK
The Korean Journal of Thoracic and Cardiovascular Surgery 1998;31(4):418-421
Thoracoscopic esophagectomy can be performed in esophageal diseases to reduce the postoperative complications. Recently, We encountered a case of esophageal cancer and successfully treated it by thoracoscopic esophagectomy with gastric pull-up. A 59-year-old male was presented with swallowing difficulty and an esophagogram, esophagoscopy, and chest CT showed an ulcerating tumor on the lower esophagus. The operation was performed in three stages: mobilization of the esophagus by thoracoscopic surgery, construction of a gastric tube through a laparotomy, and cervical anastomosis between the esophagus and the gastric pull-through. Hoarseness developed postoperatively, and the postoperative esophagogram showed leakage at the esophagogastric anastomotic site. The anastomotic leakage was healed following surgical drainage and the patient was discharged in good health. Hoarseness subsided spontaneously two months after surgery.
Anastomotic Leak
;
Deglutition
;
Drainage
;
Esophageal Diseases
;
Esophageal Neoplasms*
;
Esophagectomy*
;
Esophagoscopy
;
Esophagus
;
Hoarseness
;
Humans
;
Laparotomy
;
Male
;
Middle Aged
;
Postoperative Complications
;
Thoracoscopy
;
Tomography, X-Ray Computed
;
Ulcer
3.Treatment of Esophagojejunostomy Leakage with Expanding Stent.
Jae Gil PARK ; Sun Hi LEE ; Sung Ho LEE ; Moon Sub KWAK ; Se Wha KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 1998;31(1):77-81
It would be possible to manage the intestinal anastomotic failure with intraluminal stenting, but its reports are very rare. We experienced a effective and dramatic improvement of esophago-jejunal anastomotic leak in a esophageal and gastric double cancer patient with intraluminal stenting. The intraluminal stenting was tried at the 28th postoperative day and the anastomotic leak and inflammatory signs were disappeared about 3 weeks later. Postoperative 11th months now, the stent was moved about 1 cm downward but not changed further, and he enjoys regular diet without any problems. And we think the stenting would be helful with some limitations in the intestinal anastomotic leak patient.
Anastomotic Leak
;
Diet
;
Esophageal Neoplasms
;
Fistula
;
Humans
;
Stents*
4.A case of rickettsia-associated pancytopenia and hemophagocytosis.
Chul Woo YANG ; Seung Min KWAK ; Chong Min LEE ; Eon Sub PARK ; Suk Lae CHAE ; Wan Shik SHIN ; Moon Won KANG ; Byung Kee BANG
Korean Journal of Infectious Diseases 1992;24(3):215-220
No abstract available.
Pancytopenia*
5.Reoperation for Dysfunction of Cardiac Valve Prosthesis.
Jeong Seob YOON ; Chi Kyung KIM ; Kyu Do CHO ; Sung Ho LEE ; Moon Sub KWAK ; Se Wha KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 1998;31(3):242-246
From January 1988 to December 1995, 27 patients, 11 men and 16 women, underwent surgical intervention at our institution for prosthetic valve dysfunctions. The mean age was 43.5+/-12.2 years. Seventeen (63.0%) patients had the mitral valve replacement, 8 (29.6%) the aortic valve, 1 (3.7%) the aortic composite graft, and 1 (3.7%) the tricuspid valve. Mean follow-up period was 49.5+/-30.9 months. In 12 bioprostheses, mean interval between the previous valve replacement and the reoperation was 104.9+/-34.9 months. The causes of redo surgery were structural deterioration of the prosthetic valve (12/12, 100%), paravalvular leak (2/12, 16.7%), and prosthetic valve endocarditis (1/12, 8.3%). In 15 mechanical prostheses, the mean interval was 55.2+/-43.7 months. The causes of redo surgery were pannus formation (8/15, 53.3%), paravalvular leak (4/15, 26.7%), and valve thrombosis (3/15, 20.0%). Posto-perative complications occurred in 7 patients (25.9%). There was no intraoperative death. But one patient, who received mechanical aortic valve replacement died on the 3rd postoperative day due to low cardiac output and multiorgan failure.
Aortic Valve
;
Bioprosthesis
;
Cardiac Output, Low
;
Endocarditis
;
Female
;
Follow-Up Studies
;
Heart Valve Prosthesis*
;
Heart Valves*
;
Humans
;
Male
;
Mitral Valve
;
Prostheses and Implants
;
Reoperation*
;
Thrombosis
;
Transplants
;
Tricuspid Valve
6.Chest Wall Implantation of Lung Cancer After Percutaneous Fine Needle Biopsy: A Case Report.
Sung Bo SIM ; Sung Ho LEE ; Jong Bum KWON ; Moon Sub KWAK ; Se Wha KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 1997;30(4):445-448
Percutaneous transthoracic fine needle biopsy has been widely used In the diagnosis of pulmonary lesions especially lung cancer. Onc of the rarest complication's is that malignant cells are implanted within the needle tract and developed a chest wall mass subsequently. Wc expcrlenccd a case of chest wall implantatio of lung cancer after percutaneous transthoracic floe needle biopsy. A 65-ycar old man had undergone bilobectomy (right upper lobe and right middle lobe)for squamous cell carcinoma (T2N0M0) of the lung. 60 days after percutaneous biopsy (48 days after operation), a tiny nodule (1 mm sized) was notcd at the right anterior chcst wall where the diagnostic fine needle biopsy had been performed before operation. This tiny mass was rapidly growing to 1.5 cm sized mass for 20 days. We carried out wide excision of chest wall mass and skin grafting, and confirmed squamous cell carcinoma histopathologically as same as the lung cancer.
Biopsy
;
Biopsy, Fine-Needle*
;
Biopsy, Needle
;
Carcinoma, Squamous Cell
;
Diagnosis
;
Lung Neoplasms*
;
Lung*
;
Needles
;
Neoplasm Metastasis
;
Skin Transplantation
;
Thoracic Wall*
;
Thorax*
7.Thoracoscopic Sympathectomy for Facial Hyperhidrosis: Three Cases Report.
Jin Yong CHUNG ; Sung Mo YEON ; Gun PARK ; Moon Sub KWAK ; Suk Hun YOON
The Korean Journal of Thoracic and Cardiovascular Surgery 1998;31(3):336-338
Facial hyperhidrosis has a symptom of excessive sweating on the face with or without underlying disease. It can be surgically treated by video-assisted thoracic surgery (VATS). We encountered three cases of facial hyperhidrosis which we treated by VATS, which was performed by resection of the lower third of stellate ganglion and T2-T3 sympathetic ganglia with chains. Postoperative symptom was improved in all cases. There were no postoperative complications such as Horner's syndrome or postsympathectomy neuralgia.
Ganglia, Sympathetic
;
Horner Syndrome
;
Hyperhidrosis*
;
Neuralgia
;
Postoperative Complications
;
Stellate Ganglion
;
Sweat
;
Sweating
;
Sympathectomy*
;
Sympathetic Nervous System
;
Thoracic Surgery, Video-Assisted
8.Chylothorax after Endoscopic Thoracic Sympathicotomy: A Case Report.
Jong Bum KWON ; Chan Bum PARK ; Yong Soon WON ; Gun PARK ; Moon Sub KWAK
The Korean Journal of Thoracic and Cardiovascular Surgery 2000;33(3):273-275
Endoscopic sympathicotomy is the choice of the treatment for hyperhidrosis. There are some recognized risks such as Honer's syndrome and Hemopneumothorax; however, Chylothorax has very rarely been reported after thoracic sympathicotomy. We recently encountered a case of chylothorax. Early diagnosis and prompt treatment is noteworthy.
Chylothorax*
;
Early Diagnosis
;
Hemopneumothorax
;
Hyperhidrosis
9.Valve Replacement in an Anuric Patient with Chronic Renal Failure: 1 Case Report.
Si Hoon KIM ; Moon Sub KWAK ; Sun Hi LEE ; Jae Gil PARK ; Woong CHIN
The Korean Journal of Thoracic and Cardiovascular Surgery 1999;32(6):588-590
It is now generalized to perform cardiac surgery in the patients with end-stage renal disease. The growing number of patients with chronic renal failure wake us up to the need to prepare for proper management. There are not only the prevalence of coronary artery disease, but also a great amount of valve dysfunction exist in this group. Peritoneal dialysis may be one of the obstacles for cardiopulmonary bypass but it is not a great hindrance in cardiac surgery with careful preparation and well organized perioperative care. The author has performed mitral valve replacement in a 33-year-old anuric female patient with chronic renal failure and severe mitral insufficiency. Preoperatively, the patient was kept in adequate fluid and electrolyte balance using peritoneal dialysis. Peritoneal dialysis continued and regulated according to the laboratory data in this patient during and after the surgery. She recovered well showing an uneventful course and was discharged on postoperative 1 th day.
Adult
;
Cardiopulmonary Bypass
;
Coronary Artery Disease
;
Dialysis
;
Female
;
Humans
;
Kidney Failure, Chronic*
;
Mitral Valve
;
Mitral Valve Insufficiency
;
Perioperative Care
;
Peritoneal Dialysis
;
Prevalence
;
Thoracic Surgery
;
Water-Electrolyte Balance
10.The Effect of Platelet Derived Growth Factor on the Myocardial Revascularization in Implantation of Rabbit Internal Mammary Artery.
Yong Han KIM ; Suk Joo RHA ; Sang Hoon JUNG ; Seok Whan MOON ; Kuen Hyon JO ; Young Pil WANG ; Se Wha KIM ; Moon Sub KWAK
The Korean Journal of Thoracic and Cardiovascular Surgery 2000;33(4):277-284
BACKGROUND: Coronary artery bypases grafting in the old aged is associated with high mortality and morbidity, and it is difficult to perform if the coronary artery is diffusely disease. Recently it has been known that platelet derived growth factor(PDGF), especially PDGF-BB, stimulates angiogenesis. MATERIAL AND METHOD: New Zealand white rabbit were used. In an attempt to achieve effevtive cardiac revasculatrization without vascular anastmosis, we divided into three groups(group I : Left anterior descending artery(LAD) was occluded by ligature, group II : Bilateral internal mammary vascular pedicles were dissected and implanted into myocardium, group III : The vascular pedicles were implanted into myocardium and PDGF-BB was injected into the myocardial tissue). Two weeks after IMA implantation, the proximal region of implanted LAD was ligated. Four days after LAD ligation angiogram, triphenyl tetrazolium chloride(TTD) staining and hematoxylin eosin staining were performed. RESULT: 1. Survival rate in group II was significantly higher than that in group I (P<0.05), and survival rate in group III was signficantly higher than that in group II(53% vs 93%, P<0.01). 2. There were significant differences in the ratio of area of necrosis to area at risk between group I and group II, and between group II and group III (P<0.01). 3. Microangiogram for angiogenic response revealed wide area of extensive revascularization with patent vessels in group III. 4. Histologic findings of three groups showed that polymorphonuclear leukocyte infiltration was minimal in group II and none in group III. CONCLUSIONS: PDGF-BB can establish functinal cardiac revasculatization through systemic vessels implanted directly into the myocardium.
Blood Platelets*
;
Coronary Artery Bypass
;
Coronary Vessels
;
Eosine Yellowish-(YS)
;
Hematoxylin
;
Ligation
;
Mammary Arteries*
;
Mortality
;
Myocardial Revascularization*
;
Myocardium
;
Necrosis
;
Neutrophils
;
New Zealand
;
Platelet-Derived Growth Factor*
;
Survival Rate
;
Transplants